Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic-Rochester, Rochester, Minnesota.
Division of Biomedical Statistics and Informatics, Mayo Clinic-Rochester, Rochester, Minnesota.
Respir Care. 2021 Oct;66(10):1521-1530. doi: 10.4187/respcare.09053. Epub 2021 Aug 17.
Several markers of oxygenation are used as prognostic markers in acute hypoxemic respiratory failure. Real-world use is limited by the need for invasive measurements and unreliable availability in the electronic health record. A pragmatic, reliable, and accurate marker of acute hypoxemic respiratory failure is needed to facilitate epidemiologic studies, clinical trials, and shared decision-making with patients. [Formula: see text] is easily obtained at the bedside and from the electronic health record. The [Formula: see text] trajectory may be a valuable marker of recovery in patients with acute hypoxemic respiratory failure.
This was a historical cohort study of adult subjects admitted to an ICU with acute hypoxemic respiratory failure secondary to community-acquired pneumonia and/or ARDS.
Our study included 2,670 subjects. [Formula: see text] and [Formula: see text] were consistently more available than was [Formula: see text] in the electronic health record: ([Formula: see text] vs [Formula: see text] vs [Formula: see text] : 100 vs 100 vs 72.8% on day 1, and 100 vs 99 vs 21% on day 5). A worsening [Formula: see text] trajectory was associated with reduced ventilator-free days. From days 2 to 5, every increase in [Formula: see text] by 10% from the previous day was associated with fewer ventilator-free days (on day 2: adjusted mean -1.25 [95% CI -1.45 to -1.05] d, < .001). The [Formula: see text] trajectory also provided prognostic information. On days 3 - 5, an increase in [Formula: see text] from the previous day was associated with increased ventilator-free days (on day 3: adjusted mean 2.09 (95% CI 1.44-2.74) d; < .001). [Formula: see text] models did not add predictive information compared with models with [Formula: see text] alone (on day 2: adjusted [Formula: see text] vs [Formula: see text] R 0.122 vs 0.119; and on day 3: 0.153 vs 0.163).
[Formula: see text] and [Formula: see text] are pragmatic and readily available intermediate prognostic markers in acute hypoxic respiratory failure. The [Formula: see text] trajectory in the first 5 d of ICU admission provided important prognostic information (ventilator-free days). Although the [Formula: see text] trajectory was also associated with ventilator-free days, it did not provide more information than the [Formula: see text] trajectory alone.
有几种氧合标志物被用作急性低氧性呼吸衰竭的预后标志物。由于需要进行有创测量,并且在电子健康记录中不可靠,因此实际应用受到限制。需要一种实用、可靠和准确的急性低氧性呼吸衰竭标志物,以促进流行病学研究、临床试验和与患者的共同决策。[化学式:见文本]在床边和电子健康记录中很容易获得。[化学式:见文本]轨迹可能是急性低氧性呼吸衰竭患者恢复的有价值标志物。
这是一项回顾性队列研究,纳入了因社区获得性肺炎和/或 ARDS 导致急性低氧性呼吸衰竭而入住 ICU 的成年患者。
我们的研究纳入了 2670 名患者。[化学式:见文本]和[化学式:见文本]在电子健康记录中的可用性始终高于[化学式:见文本]:([化学式:见文本]与[化学式:见文本]与[化学式:见文本]:第 1 天 100%比 100%比 72.8%,第 5 天 100%比 99%比 21%)。[化学式:见文本]轨迹恶化与通气天数减少相关。从第 2 天到第 5 天,前一天[化学式:见文本]增加 10%与通气天数减少相关(第 2 天:调整后平均 -1.25[95%CI-1.45 至-1.05]d,<0.001)。[化学式:见文本]轨迹也提供预后信息。在第 3-5 天,前一天[化学式:见文本]增加与通气天数增加相关(第 3 天:调整后平均 2.09[95%CI1.44-2.74]d;<0.001)。与单独使用[化学式:见文本]相比,[化学式:见文本]模型没有增加预测信息(第 2 天:调整后[化学式:见文本]比[化学式:见文本]R0.122 比 0.119;第 3 天:0.153 比 0.163)。
[化学式:见文本]和[化学式:见文本]是急性低氧性呼吸衰竭中实用且易于获得的中间预后标志物。在 ICU 入院的前 5 天内,[化学式:见文本]轨迹提供了重要的预后信息(无通气天数)。尽管[化学式:见文本]轨迹也与无通气天数相关,但它没有提供比[化学式:见文本]轨迹本身更多的信息。